|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
4.75%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
4.60%
|
US
|
NASDAQ
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
4.39%
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
4.35%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
4.34%
|
US
|
NASDAQ
|
|
IART
|
Integra LifeSciences Holdings Corporation
|
4.32%
|
US
|
NASDAQ
|
|
326030
|
Sk Biopharmaceuticals Co Ltd
|
4.19%
|
KR
|
KO
|
|
IDIA
|
Idorsia Ltd
|
4.18%
|
CH
|
SW
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
4.10%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
4.04%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
4.04%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
4.03%
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
3.94%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
3.91%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
3.90%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
3.72%
|
US
|
NASDAQ
|
|
NVRO
|
Nevro Corp.
|
3.66%
|
US
|
NYSE
|
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
3.56%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
3.51%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
3.45%
|
US
|
NASDAQ
|